SCHEMBL22039675

SCHEMBL22039675

COC(=O)c1nc(Cl)cc2c1CN(C(=O)OC(C)(C)C)C2O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UCHL1 P09936 1/20 0.35
USP30 Q70CQ3 1/20 0.35
ATR Q13535 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
NR1H2 P55055 2/20 0.34
HSP90AA1 P07900 1/20 0.34
HSP90AB1 P08238 1/20 0.34
PTPN1 P18031 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ALDH1A1 P00352 1/20 0.32
CYP1A2 P05177 1/20 0.32
POLB P06746 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C19 P33261 1/20 0.32
NR1H3 Q13133 1/20 0.32
STS P08842 2/20 0.31
CHRNB4 P30926 1/20 0.31
CHRNA3 P32297 1/20 0.31
NPC1 O15118 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21990479 0.74 PIK3CA (0.36) UCHL1USP30ATRNR1H2HSP90AA1
SCHEMBL13280471 0.65 GPR119 (0.43) MEN1KMT2AALDH1A1STS
SCHEMBL22616068 0.64 ALDH1A1 (0.36) UCHL1USP30NR1H2PTPN1ALDH1A1
SCHEMBL22615640 0.64 NR1H2 (0.33) UCHL1USP30MEN1KMT2ANR1H2
SCHEMBL30428702 0.64 MEN1 (0.46) UCHL1MEN1KMT2ANR1H2PTPN1
SCHEMBL1591917 0.64 MAP4K4 (0.49) UCHL1USP30NR1H2NR1H3
SCHEMBL1591916 0.64 MAP4K4 (0.49) UCHL1USP30NR1H2NR1H3
SCHEMBL1592035 0.64 MAP4K4 (0.49) UCHL1USP30NR1H2NR1H3
SCHEMBL26639088 0.64 GRM5 (0.41) MEN1KMT2ANR1H2HSP90AA1HSP90AB1
SCHEMBL19067027 0.63 PTPN1 (0.42) USP30MEN1KMT2ANR1H2PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11142525-B2 Azalactam compounds as HPK1 inhibitors PFIZER INC. (US) 2021-10-12 US disclosed
US-20200172539-A1 Azalactam Compounds as HPK1 Inhibitors PFIZER INC. (US) 2020-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200172539-A1 Azalactam Compounds as HPK1 Inhibitors CDKN1A, HIPK1, CMPK1 UCHL1 3142/4885USP30 1783/4885ATR 2520/4885
US-11142525-B2 Azalactam compounds as HPK1 inhibitors CDKN1A, HIPK1, CMPK1 UCHL1 3142/4885USP30 1783/4885ATR 2520/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.